Access cutting-edge follicular lymphoma treatment through this clinical trial at a research site in Newark. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Newark location
Access follicular lymphoma specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related follicular lymphoma treatment provided free
Check if you qualify for this follicular lymphoma clinical trial in Newark, DE
No-Cost Study Care
Local to Newark
Convenient for DE residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Follicular lymphoma (FL) is the second most common B-cell cancer and the most common type of cancer of lymphocytes. Unfortunately, this disease is incurable with conventional treatment and the disease recurs in almost all patients. This study will assess how safe and effective epcoritamab is in combination with lenalidomide and rituximab (R2) in treating adult participants with previously untreated FL. Adverse events and change in disease condition will be assessed. Epcoritamab is an investigat
Sponsor: Genmab
Yes, this clinical trial (NCT06191744) has an active research site in Newark, DE that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for follicular lymphoma treatment options in Newark, DE, this clinical trial (NCT06191744) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Newark research site is actively enrolling participants for this clinical trial. You'll receive care from experienced follicular lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all follicular lymphoma clinical trials near you to find additional studies recruiting in your area.
See all lymphoma clinical trials recruiting in Newark — not just this study.
Browse Lymphoma Trials in Newark →